Sign Up to like & get
recommendations!
1
Published in 2021 at "CardioVascular and Interventional Radiology"
DOI: 10.1007/s00270-020-02721-0
Abstract: To determine whether low total psoas muscle area (tPMA), as a surrogate for sarcopaenia, is a predictor of adverse outcomes in patients undergoing advanced EVAR. A retrospective review of medical records was performed for 257…
read more here.
Keywords:
tpma;
adverse outcomes;
mortality;
outcomes advanced ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Indian Journal of Surgical Oncology"
DOI: 10.1007/s13193-017-0618-5
Abstract: The purpose of this study was to correlate the pattern of spread with oncological outcomes in advanced ovarian cancer patients. This is a retrospective analysis of 55 consecutive patients who had advanced epithelial ovarian cancer…
read more here.
Keywords:
pattern spread;
epithelial ovarian;
class;
advanced epithelial ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "European journal of cancer"
DOI: 10.1016/j.ejca.2020.11.035
Abstract: BACKGROUND We previously reported that PD-L1 polymorphisms are associated with the efficacy and immune-related adverse events of PD-1 blockade with nivolumab. However, the association between PD-L1 polymorphisms and survival outcomes under PD-1/PD-L1 blockade is still…
read more here.
Keywords:
advanced non;
patients treated;
survival outcomes;
outcomes advanced ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Gynecologic oncology"
DOI: 10.1016/j.ygyno.2017.07.126
Abstract: OBJECTIVES To assess the impact of frailty as measured by a frailty deficit index (FI) on outcomes in advanced epithelial ovarian cancer (EOC) after primary debulking surgery (PDS). METHODS Women with Stage IIIC/IV EOC who…
read more here.
Keywords:
index;
age;
outcomes advanced;
frailty ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Internal Medicine Journal"
DOI: 10.1111/imj.13333
Abstract: Neuroendocrine tumours (NET) arise from neuroendocrine cells, which are widely distributed throughout the body. However, diagnosing NET is difficult due to nonspecific symptoms and the paucity of experience among health professionals. This retrospective study was…
read more here.
Keywords:
treatment outcomes;
profile treatment;
outcomes advanced;
neuroendocrine tumours ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.15_suppl.9591
Abstract: 9591Background: EGFR x19dels are well-established targetable drivers in NSCLC. Historically x19dels have been treated as a single group, but it’s unclear whether responses vary for distinct subtype...
read more here.
Keywords:
real world;
advanced non;
world outcomes;
outcomes advanced ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.29_suppl.140
Abstract: 140Background: Prior studies have suggested that patient-reported outcomes may be associated with cancer outcomes. We evaluated the association between clinically significant fatigue (CSF) and adve...
read more here.
Keywords:
association patient;
fatigue;
fatigue outcomes;
outcomes advanced ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.4_suppl.687
Abstract: 687Background: The current study aims at assessing the patterns of opioid use, and evaluating the impact of opioid use on survival outcomes among patients with advanced GI cancers who were included...
read more here.
Keywords:
advanced gastrointestinal;
use;
opioid use;
gastrointestinal cancer ... See more keywords